# Safety/Effectiveness of Adding Monthly Dexamethasone to Weekly Avonex for MS

> **NCT00232193** · — · COMPLETED · sponsor: **Providence Multiple Sclerosis Center** · enrollment: 40 (actual)

## Conditions studied

- Relapsing-remitting Multiple Sclerosis
- Clinically Isolated Syndrome

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT00232193
- **Lead sponsor:** Providence Multiple Sclerosis Center
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2003-12
- **Primary completion:** 2008-12
- **Final completion:** 2010-08
- **Target enrollment:** 40 (ACTUAL)
- **Last updated:** 2011-07-22

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00232193

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00232193, "Safety/Effectiveness of Adding Monthly Dexamethasone to Weekly Avonex for MS". Retrieved via AI Analytics 2026-09-27 from https://api.ai-analytics.org/clinical/NCT00232193. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*